These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8444273)

  • 1. Suppression of lipolysis in normal man does not inhibit recovery from insulin-induced hypoglycaemia.
    Newrick PG; Braatvedt G; Stansbie D; Corrall RJ
    Eur J Clin Invest; 1993 Jan; 23(1):53-6. PubMed ID: 8444273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-hypoglycaemic hyperketonaemia does not contribute to brain metabolism during insulin-induced hypoglycaemia in humans.
    Fanelli C; Di Vincenzo A; Modarelli F; Lepore M; Ciofetta M; Epifano L; Pampanelli S; Brunetti P; Bolli GB
    Diabetologia; 1993 Nov; 36(11):1191-7. PubMed ID: 8270135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of adipose tissue lipolysis following insulin-induced hypoglycaemia: evidence of increased beta-adrenoceptor-mediated lipolytic response in IDDM.
    Bolinder J; Sjöberg S; Arner P
    Diabetologia; 1996 Jul; 39(7):845-53. PubMed ID: 8817110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of an acute decrease in non-esterified fatty acid levels on muscle glucose utilization and forearm indirect calorimetry in lean NIDDM patients.
    Piatti PM; Monti LD; Davis SN; Conti M; Brown MD; Pozza G; Alberti KG
    Diabetologia; 1996 Jan; 39(1):103-12. PubMed ID: 8720610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute metabolic and hormonal responses to the inhibition of lipolysis in non-obese patients with non-insulin-dependent (type 2) diabetes mellitus: effects of acipimox.
    Fulcher GR; Walker M; Catalano C; Farrer M; Alberti KG
    Clin Sci (Lond); 1992 May; 82(5):565-71. PubMed ID: 1317767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
    Pontiroli AE; Manzoni MF; Malighetti ME; Lanzi R
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3998-4001. PubMed ID: 8923850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of changes in plasma nonesterified fatty acid levels on oxidative metabolism during moderate exercise in patients with non-insulin-dependent diabetes mellitus.
    Akanji AO; Osifo E; Kirk M; Hockaday TD
    Metabolism; 1993 Apr; 42(4):426-34. PubMed ID: 8487664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.
    Bajaj M; Suraamornkul S; Romanelli A; Cline GW; Mandarino LJ; Shulman GI; DeFronzo RA
    Diabetes; 2005 Nov; 54(11):3148-53. PubMed ID: 16249438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of catecholamines in defense against insulin hypoglycemia in humans.
    Bolli GB
    Adv Pharmacol; 1998; 42():627-30. PubMed ID: 9327980
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of lipolysis by nicotinic acid and by acipimox.
    Fuccella LM; Goldaniga G; Lovisolo P; Maggi E; Musatti L; Mandelli V; Sirtori CR
    Clin Pharmacol Ther; 1980 Dec; 28(6):790-5. PubMed ID: 7438693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of acute inhibition of lipolysis on operation of the glucose-fatty acid cycle in hepatic cirrhosis.
    Farrer M; Fulcher GR; Johnson AJ; Record CO; Alberti KG
    Metabolism; 1992 May; 41(5):465-70. PubMed ID: 1588824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do in-vivo suppression and stimulation of lipolysis influence thyroid hormone levels in man?
    Newrick PG; Braatvedt G; Stansbie D; Corrall RJ
    J Endocrinol; 1991 Jul; 130(1):155-7. PubMed ID: 1880475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute pharmacologic blockade of lipolysis normalizes nocturnal growth hormone levels and pulsatility in obese subjects.
    Andreotti AC; Lanzi R; Manzoni MF; Caumo A; Moreschi A; Pontiroli AE
    Metabolism; 1994 Oct; 43(10):1207-13. PubMed ID: 7934970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of lipolysis in Type 2 diabetes normalizes glucose disposal without change in muscle glycogen synthesis rates.
    Lim EL; Hollingsworth KG; Smith FE; Thelwall PE; Taylor R
    Clin Sci (Lond); 2011 Aug; 121(4):169-77. PubMed ID: 21388348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of a sustained-release preparation of acipimox on dyslipidemia and glucose metabolism in non-insulin-dependent diabetes mellitus.
    Davoren PM; Kelly W; Gries FA; Hubinger A; Whately-Smith C; Alberti KG
    Metabolism; 1998 Mar; 47(3):250-6. PubMed ID: 9500558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin levels in humans are acutely suppressed by isoproterenol despite acipimox-induced inhibition of lipolysis, but not by free fatty acids.
    Stumvoll M; Fritsche A; Tschritter O; Lehmann R; Wahl HG; Renn W; Häring H
    Metabolism; 2000 Mar; 49(3):335-9. PubMed ID: 10726911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis.
    Lucidi P; Rossetti P; Porcellati F; Pampanelli S; Candeloro P; Andreoli AM; Perriello G; Bolli GB; Fanelli CG
    Diabetes; 2010 Jun; 59(6):1349-57. PubMed ID: 20299466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects.
    Fulcher GR; Walker M; Catalano C; Agius L; Alberti KG
    Diabetes; 1992 Nov; 41(11):1400-8. PubMed ID: 1397716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute inhibition of lipolysis does not affect postprandial suppression of endogenous glucose production.
    Carey PE; Gerrard J; Cline GW; Dalla Man C; English PT; Firbank MJ; Cobelli C; Taylor R
    Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E941-7. PubMed ID: 15998660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans.
    Carpentier AC; Frisch F; Cyr D; Généreux P; Patterson BW; Giguère R; Baillargeon JP
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E849-56. PubMed ID: 15972273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.